Submissions

Online Submissions

Already have a Username/Password for Journal of Modern Oncology?
Go to Login

Need a Username/Password?
Go to Registration

Registration and login are required for submitting items online, and for checking the status of current submissions.

 

Author Guidelines

We strive to comply with the most up-today industry requirements developed by such organizations as the International Committee of Medical Journal Editors. Please see our relevant policy outlined below.

  1. Manuscript requirements. We accept submissions strictly online, via the form available at our website.
    Please upload your manuscript as a Microsoft Office Word document (*.doc, *.docx and *.rtf formats).
  2. Length of the manuscript from an original study or literature review (including tables and list of references) should not exceed 6000 words. Case reports should be limited to 4000 words, short reports and letters to the editor should not exceed 1500 words. Please consult the MS Word built-in statistics service prior to submission in order to find out the exact length of your manuscript. Should your manuscript exceed the aforementioned limits, the editorial board will carry out the final decision on its publication based on recommendations from your reviewer.
  3. Text formatting.Lettering in Times New Roman is preferable in all cases (font size 12 pt with 1.0 line spacing and 2 cm margins). Kindly refrain from using underlining in your document (italic and bold formatting is acceptable).
  4. File structure. Although the journal editorial board prefers to receive a manuscript as a single complete file with all figures, tables and any additional supplemental materials, there is a way for submitting figures, table and other supplementary material like video as separate files. For more details, please see section IV below.
  5. Please organize your text according to the following template:
  • Article title.Best article titles bear short, clear and distinctive messages
  • Corresponding Author.One author has been designated as the corresponding author with contact details: • E-mail address• Full postal address
  • Authors and their affiliated institutions, linked by superscript numbers, should be listed beneath the title on the opening page of the manuscript.
  • Abstract of an original studyshould start with some brief background information and statement of the study’s OBJECTIVE, followed by MATERIALS & METHODS and finishing with the RESULTS. The closing sentence should outline the main CONCLUSIONS of the study in the most comprehensible terms. Please note that your abstract should be 300 words or less.
  • Choice of keywords. MeSH(Medical Subject Headings) thesaurus is a preferred source for choosing keywords.
  • The body of the textshould start with a brief introduction, describing the paper’s significance. In the case of an original study, the body of the paper should follow a common structured approach to the description of the studies aim, its materials, methods and results, as well as Discussion and Conclusions sections.
  • Acknowledgements section shall comprise the following:
    • Clarification regarding any potential or actual conflicts of interest of the authors. Any affiliations, financial relations, financial or political interests in the manuscript as a whole or in part, including employment and other liabilities that may result in withholding or deliberate corruption of data or adversely influenced interpretation, are considered a conflict of interest and must be explicitly stated as such. Please note that conflicts of interest do not impede a publication, though failure to disclose one does.
    • A brief list of funding sources for the results reported in the paper, as well as the publication process itself (e.g. a commercial organization, a foundation or government grant, etc.).
    • An optional note describing the roles or responsibilities of the authors. You may also place here an acknowledgment for any individuals or organizations that assisted in your work.
  1. List of references should be organized according to the guidelines by U.S. National Information Standards Organization in Vancouver style. The following are the principle points you should be aware of while preparing your manuscript for submission:

            o     References should be numbered in the order in which they are cited.

            o     Number of references is limited to 60 for literature reviews, and to 20 for original studies and lectures.

            o     Within the body of the text references should be provided in Arabic numerals enclosed in square brackets.

            o     A complete list of all authors should be presented in every bibliographical entry. Please put an “et al.” notation after the third name if cited paper has more than 4 authors. Do not shorten titles of your citations. Shortened journal titles should correspond to the MedLine catalogue. If the journal is not indexed by MedLine, please provide its full title.

     III.        Enumerate your tables, give those a heading and clearly marked columns that would be easy to read and comprehend. Please make sure that table data is in line with the numbers in the body of the text (but does not simply duplicate them).

  1. Reduce graphical material to minimum (unless the nature of your study dictates otherwise). Photographs should be rich in contrast, illustrative artwork – clear and of high resolution (dpi). 
  • If you wish to include in your paper any graphical material created other than by means of standard office applications (e.g. results of diagnostic imaging, photographs, screenshots, digital artwork, etc.), please submit them as separate files via our web form in *.jpeg, *.bmp or *.gif formats. The absolute minimum for acceptable resolution is 300 dpi, though higher is preferable. Do keep in mind that image files should be tagged with numbers corresponding to the enumeration within the manuscript. In addition, file description should provide the caption of your image as it would appear in the paper          
    (exp.: “Fig. 1. Elliott Proctor Joslin, M.D. (1869-1962).”).
  • Graphs should be labeled on the ordinate and abscissa with the parameter or variable being measured, the units of measure, and the scale.
  • Units should be metric and follow SI convention.
  • Kindly take care to provide references to all of your supplementary materials (tables, graphs, etc.) within the body of the text.
  1. Ethical statement. In accordance with COPE (Committee on Publication Ethics) guidance authors must provide an ethical statement if the study included use of human or animal subjects and/or tissue. Approval from the relevant body is required for studies involving: 
  • humans (live or tissue), including studies that are observational, survey-based, or include any personal data;
  • animals (live or tissue), including observational studies;
  • non-commercial cell lines.
  1. Cover letter.  In a Cover Letter authors should:
  • Introduce the material sent to the journal, and comment on its appropriateness for the journal or other reasons that prompted submission. 
  • Indicate type of article
  • Indicate, if appropriate, that they have followed the specific EQUATOR reporting guidelinesfor their type of study.
  • Provide for clinical trials involving intervention the trial registration number and the name of the publicly accessible registry (such as http://www.clinicaltrials.govhttp://isrctn.org, or one of the WHO Primary Registries that meet the ICMJE requirements: http://www.who.int/ictrp/network/primary/en/) in which the trial has been registered. For clinical trials commenced after 1 July 2008 the registration must have been prospectively done.
  • Inform the Editors of any special circumstances or details regarding the submitted material, including prior submission/publication of the material or parts of the material to another journal or another language.
  • Explain in a separate paragraph of the Cover Letter each author's contribution required (contributions to authorship are not published in the journal though).

   VII.        Editorial feedback Within the next 7 days the editorial board will inform of receiving the manuscript. A decision on acceptance or rejection is usually taken within 4 weeks.

 

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with each of the following items, and submissions that do not adhere to these guidelines may be returned to the authors.

  • Cover Letter to include: 

    • Article type
    • Title, authors (including their ORCID), affiliations, abstract, etc.
    • Each author’s contribution
    • Corresponding author details
    • Relevance of the manuscript to the journal
    • Conflict of Interest Statement
    • Ethical statement
    • Trial registration in case of use of human or animal subjects
    • Funding information
    • Supporting information (legends of attached figures, tables and list other attached files) 
    • Possible reviewers suggestions and their contacts
  • The manuscript is accepted only if it has not been published or is not being submitted for publication elsewhere.

  • The manuscript shall be double-checked to comply with required language, style and format.

  • Should the main text of the manuscript contain information about the authors and/ or their affiliations, please provide separately the main manuscript text where such information is blanked in order to comply with double-blind review standards.

  • Other files properly numbered and indicated in a Cover Letter.

 

Copyright Notice

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International Licensee (CC BY-NC-SA 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to use published version of the work for educational and not-for-profit proposes (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical 'JOURNAL OF MODERN ONCOLOGY'.

READ the details online (tap to see in details)

Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical 'JOURNAL OF MODERN ONCOLOGY'

The editorial board of the JOURNAL OF MODERN ONCOLOGY (ISSN 1815-1434 (Print), ISSN 1815-1442 (Online), mass media registration certificate ПИ № ФС 77-63964 dated 18.12.2015, ЭЛ № ФС 77-69203 dated 24.03.2017) represented by editor-in-chief Irina V. Poddubnaya, acting under the Charter (hereinafter referred to as the Licensee), on one side, and the representative of the authors' team (hereinafter referred to as the Licensor), on the other side, hereinafter together referred to as Parties, have concluded this agreement (hereinafter referred to as Agreement) on publication of scientific work (hereinafter referred to as Work) in the JOURNAL OF MODERN ONCOLOGY (hereinafter referred to as the Journal) under the terms and conditions set forth below.

  1. General provisions
    • This Agreement under clause 2 Art. 437 of the Civil Code of the Russian Federation is a public offer (hereinafter referred to as Offer), full and unconditional acceptance of which following Art. 438 of the Civil Code of the Russian Federation is deemed to be the submission by the Licensor of the Work by uploading it to the online electronic system for accepting manuscripts for review in the relevant section of the Journal's website on the information and telecommunication network Internet (hereinafter referred to as the Internet).
  2. Terms used in the Agreement
    • Acceptance of the Offer is full and unconditional acceptance of the Offer on the terms and conditions specified in paragraph 4 of the Agreement (the Licensor accepts the Offer by sending an Application to the Licensee — uploading the Work and accompanying materials in the online electronic system of acceptance of articles for review in the relevant section of the Journal's website on the Internet).
    • The Journal is a peer-reviewed scientific journal registered as a mass medium in the register of Roskomnadzor (the mass media registration certificate ПИ № ФС77-64546 dated 22.01.2016).
    • The Application is an electronic application of the Licensor to the Licensee for publication of the Work in the Journal by uploading the Work and accompanying materials to the online electronic system of accepting manuscripts for review in the relevant section of the Journal's website on the Internet.
    • The Licensor is an individual, a representative of the authors' group, by whose creative work the Work was created.
    • The Licensee is the Editorial Board of the mass medium JOURNAL OF MODERN ONCOLOGY represented by the Editor-in-Chief.
    • Metadata is information in Russian and English intended for inclusion in International Scientific Databases (ISDB), namely:
      • the title of the Work;
      • information about the authors (last name, first name, patronymic of the author (authors) in full, place of work of each author indicating his/her postal address, contact information (email), ISDB identifiers for each author;
      • abstract;
      • keywords;
      • subject heading: UDC or other library and bibliographic classification and subject indexes;
      • bibliographic list (references).
    • Offer is this document (offer to the Licensor) to publish the Work by posting it on the Journal's website.
    • Work is the result of fundamental and/or applied scientific research in the form of scientific material, review scientific material, scientific communication, bibliographic review on certain topics of scientific research, historical note on figures of Russian and foreign science, submitted by the Author for publication in the Journal.
    • Publication is placement of an Article in the Journal.
    • Article is a Work that has undergone the process of review and
    • editorial processing.
    • Parties are the Licensor and the Licensee.
    • Requirements for manuscripts are the requirements for materials published in the Journal, available in the "Authors" section of the Journal's website on the Internet.
  3. Subject of the Agreement (Offer)
    • Under this Agreement, the Licensor grants to the Licensee an exclusive license to use the Work, free of charge, within the limits and for the period specified in the Agreement.
    • The Licensor warrants that it holds the exclusive copyright in the Work transferred to the Licensee.
  4. Rights and obligations of the Parties
    • The Licensor grants c Licensee the following rights for the duration of the exclusive rights to the Work:
      • the right to review and, if the manuscript of the Work is accepted, to make literary and scientific editing and proofreading;
      • the right to reproduce the Work (to publish, make public, duplicate, replicate or otherwise reproduce the Work) without limitation of the number of copies (upon that each copy of the Work shall contain the name of the author of the Work);
      • the right to distribute the Work by any means throughout the world;
      • the right to post the Work in electronic format on the Journal's website;
      • the right to translate the Work into any languages;
      • the right of public disclosure;
      • the right to use the metadata (title, author's (copyright holder's) name, abstracts, bibliographic materials, etc.) of the Works by disseminating and making available to the public, processing, and systematization, as well as inclusion in various databases and information systems on the Internet in the public domain;
      • the right to assign, on contractual terms, some or all of the rights obtained hereunder to third parties without payment of remuneration to the Work.
    • Other rights not expressly granted to the Licensee hereunder, including patent rights in any processes, methods, or techniques and the like described by the Licensor in the Work, as well as trademark rights, are reserved by the Licensor and other rights holders.
    • The Licensee has the right to request, and the Licensor undertakes to provide, if necessary, source (raw) data as well as other information and documents required for an objective review of the manuscript of the Work and compliance with ethical standards of scientific and medical publications therein (e.g., copies of the ethics committee resolution, informed patient consent, etc.).
    • The Licensee undertakes to observe the copyrights stipulated by the current legislation, the Licensor's rights, as well as to protect them and to take all possible measures to prevent infringement of copyrights by third parties.
    • The territory in which the rights to the Works may be used is unlimited.
    • The Licensor also grants the Licensee the right to store and process the following personal data without a time limit for all authors of the Work:
      • name, patronymic, last name;
      • date of birth;
      • educational background;
      • information on the place of work and the position held;
      • information on the published works of literature, science and art;
      • the international identification number ORCID and the data contained therein.
    • Personal data are provided for their storage and processing in various databases and information systems, their inclusion in analytical and statistical reporting, the creation of a reasonable connection between the objects of science, literature, and art with personal data, etc.
    • The Licensee has the right to transfer this data for processing and storage to third parties, provided that the Licensee notifies the third party of this fact and provides information about the third party (name and address) to the Licensor.
  5. Warranties and responsibilities of the Parties
    • At the time of signing this Agreement, the Licensor warrants that it holds the exclusive copyright in the Work transferred to the Licensee and that at the time of granting the Licensee the right to the Work, it has not given any instructions that would conflict with the rights transferred to the Licensee under the Agreement.
    • The Licensor warrants that this Work has not been previously contractually transferred to anyone for reproduction or other use.
    • The Licensor warrants that the Work does not contain any copyrighted material of which it is not the copyright holder. If the Work incorporates copyrighted material owned by another person, the Licensor undertakes to obtain at its own cost and expense all necessary rights to use this material in the Work and to bear the property liability associated with the unauthorized use in the Work of copyrighted material belonging to other authors or other right holders. The Licensor agrees to indemnify the Licensee against all third-party claims caused by or arising out of any breach of the warranties and obligations stipulated above.
    • The Licensor confirms that it has read and understood the instructions for authors and the publication ethics for authors and typical examples of violations (including plagiarism, multiple submissions, improper authorship, and other examples of violations).
    • If any material in the Work is found which is not owned by the Licensor, or any other infringement in accordance with cl. 3.4. the Licensor may be denied placement of the Work. If the Work has already been published at the time such material or infringement is discovered, it may be revoked (retracted) or withdrawn entirely from the electronic version, in accordance with international and national guidelines and recommendations on publication ethics of scientific journals (including https://publicationethics.org and https://rasep.ru/sovet-po-etike/deklaratsiya).
    • The Licensee is not account for the content of the Work. In the event of disputes concerning the rights to the work, the Licensor takes full responsibility for the settlement of these disputes and bears moral and financial responsibility.
    • The Parties shall be liable, under the current legislation of the Russian Federation, for non-fulfillment or improper fulfillment of their obligations under this Agreement.
    • The Party that improperly performs or fails to perform its obligations hereunder shall be obliged to reimburse losses incurred by the other Party, including lost profits.
  6. Acceptance of the Offer and conclusion of the Agreement Term of the Agreement
    • This Agreement shall become effective on the date of its conclusion when the Licensor accepts the Offer by sending the Application to the Licensee and shall be valid for the duration of the exclusive rights to the Article.
    • Acceptance of the Offer by the Licensor creates an Agreement concluded in writing (Articles 438 and 1286.1 of the Russian Federation Civil Code) on the Offer conditions.
  7. Procedure for amendment and termination of the Agreement
    • The Licensee has the right to unilaterally change the terms of this Agreement by notifying the Licensor through the Journal's website or by sending a notice via e-mail to the e-mail address of the Licensor specified in the Application of the Licensor at least ten (10) calendar days prior to the effective date of the relevant changes. The amendments shall become effective on the date specified in the notice.
    • In case the Licensor disagrees with the changes in the terms of this Agreement, the Licensor has the right to send the Licensee a written notice of withdrawal from this Agreement by uploading the notice to the online electronic system of accepting articles for review available in the relevant section of the Journal's website) or sending the notice to the official e-mail address of the Editorial Board on the Internet)
    • This Agreement may be brought to an early termination:
      • by mutual consent of the Parties at any time;
      • on other grounds stipulated by this Agreement.
    • The Licensor has the right to unilaterally withdraw from this Agreement by giving the Licensee a corresponding notice in writing not less than sixty (60) calendar days prior to the intended date of publication of the Work by the Licensor in the Journal.
    • Termination of the Agreement for any reason shall not relieve the Parties from liability for breach of the terms and conditions of the Agreement arising during the term of its validity.
  8. Liability
    • For non-fulfillment or improper fulfillment of their obligations under the Agreement the Parties shall be liable in accordance with the current legislation of the Russian Federation.
    • All information provided by the Licensor must be accurate. The Licensor is responsible for the accuracy and completeness of the information transferred to the Licensee. When using inaccurate information received from the Licensor, the Licensee shall not be liable for any adverse consequences caused by its actions based on the provided inaccurate information.
    • Concerning the content of the Article, the Licensor shall be solely responsible for compliance with the requirements of Russian legislation on advertising, protection of copyright and related rights, protection of trademarks and service marks, and protection of consumer rights.
    • The Licensee shall not have any liability under the Agreement:
      • for any actions resulting directly or indirectly from misconduct of the Licensor;
      • for any losses of the Licensor regardless of whether the Licensee could have foreseen the possibility of such losses or not.
    • The Licensee shall be exempt from liability for breach of the terms and conditions of the Agreement if such breach is caused by force majeure, including actions of public authorities (including the adoption of legal acts), fire, flood, earthquake, other natural disasters, power outage and/or computer network failures, strikes, civil unrest, riots, any other circumstances.
  9. Dispute settlement procedure
    • Disputes and disagreements shall be resolved by the Parties by negotiations and in case of failure to reach an agreement following the current legislation of the Russian Federation.
    • In case of unresolved disputes between the Parties, the disputes shall be resolved in the court according to the location of the Licensee following the current legislation of the Russian Federation.
  10. Other terms and conditions
    • Any notifications, messages, requests, etc. (except for the documents to be sent in the form of original copies under the legislation of the Russian Federation) shall be deemed received by the Licensor if they have been transmitted (sent) by the Licensee via the Journal's website (including by publication), by fax, by e-mail specified in the Application and other communication channels. The Parties acknowledge the legal validity of notices, messages, requests, etc., transmitted (sent) in the abovementioned ways.
    • In case of claims against the Licensee related to the infringement of exclusive copyright and other intellectual property rights of third parties in the creation of the Article or in connection with the conclusion of this Agreement, as well as in connection with the use of the Work by the Licensee in accordance with the Agreement, the Licensor shall be obliged:
      • immediately upon receipt of the Licensee's notice, take measures to settle disputes with third parties, if necessary, enter into litigation on the side of the Licensee and take all actions in its power to exclude the Licensee from the list of defendants;
      • reimburse to the Licensee the legal costs incurred, costs and losses caused by the application of measures of securing the claim and execution of a court decision, and amounts paid to a third party for violation of exclusive copyright and other intellectual property rights, as well as other losses incurred by the Licensee due to non-compliance with the guarantees provided by the Licensor under this Agreement.
  1. Registered office address and administrative details of the Licensee 
    • Editor-in-Chief, Journal of Modern Oncology
      Irina V. Poddubnaya 
    • Publisher: Consilium Medicum
    • Address: Moscow, ul. Alabyan d. 13, k. 1, etazh 3, pom. XXVIIIA
    • Taxpayer Identification Number (INN): 7714456747;
      Tax Registration Reason Code (KPP): 774301001;
      Primary State Registration Number (OGRN): 1197746753137;
      Russian Business and Organization Classification (OKPO): 42874998.

 

Privacy Statement

The editorial Board of the journal and the administration of the website of the journal do not transfer personal information in any way specified by the users when working with the website of the journal to third parties, except for those cases and to the extent specified in the terms of the copyright agreement.

The affiliation work and e-mail address of the authors of the manuscript accepted for publication will be published in the section "information about the authors" of the printed version of the journal and in the section "about the authors" on the page of the article on the website of the journal.

The phone number of the corresponding author will be known only to the editorial Board Secretariat and will only be used in cases of emergency.

 

Author Fees

The publisher of the "Modern oncology" journal charges the authors an Article Processing Change (APC) to provide them a high quality peer-review, timely editorial management and manuscript preparation process. 

The APC is for:

  • Initial check of the article for compliance with editorial requirements and Author Guidelines
  • Checking the manuscript for plagiarism using the Antiplagiat system
  • Organization of the multilevel peer-review process, provide recommendation from reviewers to authors for a manuscript revising
  • Transferring of the article and reviwers' recommendations to the editorial board
  • Informing the authors of the Editorial Board's decisions

APC is a mandatory payment, it and can be made during or after a manuscript submitting process via the editorial workflow system or through the direct bank transfer after the submission is compleate. Until the payment is made, the manuscript is not considered by editors and peer-reviewers.

APC does not guarantee the publication. The final decision on the publication of the manuscript is made by the Editorial Board and personally by the Editor-in-Chief.

If a manuscript is not accepted for publication (because of non-compliance with the terms of the author's agreement by the authors, negative peer-reviewers conclusions, exceeding the deadlines for revising the manuscript, refusal to revise the manuscript in accordance with the Author Guidelines, violation of the principles of publication ethics and refusal to editorial board) the APC is non-refundable.


Standard Review Process

Price: 630.00 (EUR)

MANDATORY FEE

The time taken to review manuscripts under the standard review procedure from their submission to a decision by the Editorial Board on publication or rejection is 45 to 120 days. The review procedure is fully compliant with the Editorial Policies (for more information see here). If a favorable decision is made, a manuscript is published in a respective section of the journal issue.


FastTrack Peer-Review and Publication:

Price: 925.00 (EUR)

OPTIONAL FEE

Should a faster expert assessment (peer-review) of submission and an editorial decision on possible publishing be required, the Authors can take advantage of the (FastTrack) peer-review process. If the Authors opt for FastTrack peer-review and publication, the editorial guarantees:

  • a submission is peer-reviewed (including its peer-review and a final editorial decision to publish or reject) within 21 days from payment;
  • in a case of editorial acceptance the manuscript will be publish Online First (Ahead-of-Print) within 14 days after its acceptance.

The FastTrack option does not preclude the need to follow submission requirements and Author Guidelines.

The editorial does not guarantee a favorable decision on publication for submissions peer-reviewed under the FastTrack option; however it guarantees that the timing of peer-review and all other editorial processes of submission assessment is expedited, including an unscheduled (urgent) meeting of the Editorial Board to make a decision on possibility to publish the manuscript. Therefore, if negative feedback is provided during peer-review, and the Editorial Board takes sides with the reviewers, the submission will be rejected. In this case the conditions of the FastTrack peer-review process are considered fulfilled (provided the authors receive a response within 21 days after payment). If the reviewers recommend any refinements to be made into the manuscript, a final editorial decision will be made with due consideration of the recommended corrections.

To activate the FastTrack peer-review and publication service, authors should make payment from the user account on the journal’s website after submission. As soon as the payment is made and a notification to the editorial is sent, the author receives an email confirmation; a decision following the submission peer-review is sent within 21 days.


Publication in Online First section (Ahead-of-Print):

Price: 550.00 (EUR)

OPTIONAL FEE

This option is available in cases when the manuscript has been accepted for publication, but the Authors want to publish it in electronic format within one month after the editorial decision prior to print issue date. The Authors should not make payment unless they receive a conformation that the manuscript has been accepted for publication.


Payment procedure

  • Online payment during submission. The payment is made online during manuscript submission (at final step). After payment, the author submitting a manuscript receives a receipt for successful payment for submission. The editorial simultaneously receives a notification of a new submission.
  • Offline after submission. The Authors can sign an agreement with the publishing company for one or several of the above-mentioned options and make payment by a bank wire transfer. The agreement templates and details of the publishing company can be requested from managers (link).

Discount Policy

The editorial and the publisher consider that the lack of opportunity to pay should not be a barrier to publication of a high-quality research paper that can be significant for the medical community. The publication fee can be reduced or cancelled by the decision of the Editorial Board following a request from the authors. In this case an appropriate petition signed by the leader of the authors team on the letterhead of the institution carrying out the research should be sent to the editorial.




This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies